Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex322_47.htm |
| EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex321_48.htm |
| EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex312_49.htm |
| EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex311_50.htm |
| EX-21.1 - EX-21.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex211_51.htm |
| 10-K - 10-K - ALNYLAM PHARMACEUTICALS, INC. | alny-10k_20171231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-8 (Nos. 333-190498, 333-127450, 333-116151, 333-148114, 333-157633, 333-165105, 333-172370, 333-207251 and 333-219840) and Form S-3 (No. 333-217688) of Alnylam Pharmaceuticals, Inc. of our report dated February 15, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 15, 2018